Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07285655
PHASE3

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Sponsor: Liquidia Technologies, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by interstitial lung disease (PH-ILD, WHO Group 3). One of the main ways the study will check this is by seeing if people can walk further in six minutes (called the "six-minute walk test"). Another important (secondary) goal is to see how long it takes for PH-ILD to get worse while people are taking L606. One way the study will measure this is by looking at the distance people walk at different times in the study on different doses of L606. Throughout the study, doctors will also closely monitor for any side effects people have to make sure L606 is safe. People who decide to join this study will be randomly (like tossing a coin) placed into one of two groups: one group will get L606 and the other group will get a placebo, which will look like L606 but will not contain any active medicine. At the end of the initial blinded portion of the study, study participants may have the opportunity to enroll in an open-label extension portion of the study where all participants will receive L606.

Official title: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

344

Start Date

2026-04-23

Completion Date

2031-12

Last Updated

2026-09-02

Healthy Volunteers

No

Interventions

DRUG

L606

L606 is a liposomal version of treprostinil intended for delivery via oral inhalation using a study issued nebulizer.

DRUG

Placebo

Placebo will match L606 but contain no treprostinil.

Locations (36)

Dignity Health - St. Joseph's Hospital and Medical Center

Phoenix, Arizona, United States

Arizona Pulmonary Specialists, Ltd.

Scottsdale, Arizona, United States

David Geffen School of Medicine at UCLA

Los Angeles, California, United States

University of California, San Francisco

San Francisco, California, United States

University of Colorado Hospital

Aurora, Colorado, United States

National Jewish Hospital

Denver, Colorado, United States

Tampa General Hospital

Tampa, Florida, United States

Northwestern University

Chicago, Illinois, United States

St. Vincent Cardiovascular Research Institute

Indianapolis, Indiana, United States

NYU Langone Health

New York, New York, United States

University of Rochester Medical Center

Rochester, New York, United States

Summit Health

Bend, Oregon, United States

Royal Hobart Hospital

Hobart, Tasmania, Australia

Ordensklinikum Linz GmbH

Linz, Austria

Universitair Ziekenhuis Gent

Ghent, Belgium

Assistance Publique Hopitaux De Paris

Le Kremlin-Bicêtre, France

Universitaetsklinikum Koeln AöR

Cologne, Germany

Universitätsklinikum Giessen und Marburg - Standort Giessen

Giessen, Germany

Universitaetsmedizin Greifswald KöR

Greifswald, Germany

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

Medizinische Hochschule Hannover

Hanover, Germany

Krankenhaus Neuwittelsbach

Munich, Germany

LMU Klinikum Muenchen AöR

Munich, Germany

IRCCS Ospedale Policlinico San Martino

Genoa, Italy

Azienda Ospedaliero-Universitaria Policlinico Umberto I

Rome, Italy

Pauls Stradinš Clinical University Hospital

Riga, Latvia

Unidade Local De Saude De Almada-Seixal E.P.E.

Almada, Portugal

Unidade Local De Saude De Santo Antonio E.P.E.

Porto, Portugal

Hospital Del Mar

Barcelona, Spain

Hospital Clinic De Barcelona

Barcelona, Spain

Hospital Universitario Marques De Valdecilla

Santander, Spain

Royal United Hospitals Bath NHS Foundation Trust

Bath, United Kingdom

Royal Free London NHS Foundation Trust Hospital - Royal Free Hospital

London, United Kingdom

Royal Bromptom Hospital

London, United Kingdom

University Hospitals Plymouth NHS Trust - Derriford Hospital

Plymouth, United Kingdom

Sheffield Teaching Hospital NHS Foundation Trust - Royal Hallamshire Hospital

Sheffield, United Kingdom